Literature DB >> 10952641

Outcome of invasive pneumococcal disease: a UK based study. Oxford Pneumococcal Surveillance Group.

F Shackley1, K Knox, J B Morris, D Crook, D Griffiths, R Mayon-White, R George, L Willocks, E Moxon.   

Abstract

METHODS: The records of 106 children aged less than 5 years with invasive disease caused by Streptococcus pneumoniae were reviewed.
RESULTS: The clinical manifestations were meningitis (37%), upper respiratory tract infection (24%), pneumonia (19%), and occult bacteraemia (18%). One child died and seven had persisting neurological impairment. Five serotypes caused 83% of disease and 92% of the serotypes are included in the seven valent conjugate vaccines which are undergoing trials.
CONCLUSIONS: These data suggest that S pneumoniae infection is associated with a low case fatality rate but substantial morbidity in the UK.

Entities:  

Mesh:

Year:  2000        PMID: 10952641      PMCID: PMC1718475          DOI: 10.1136/adc.83.3.231

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989.

Authors:  A Fenoll; C Martín Bourgon; R Muñóz; D Vicioso; J Casal
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

2.  Mortality from acute respiratory infections in children under 5 years of age: global estimates.

Authors:  J Leowski
Journal:  World Health Stat Q       Date:  1986

3.  Distribution of serotypes and antibiotic resistance among pneumococci in Northern Ireland.

Authors:  A C Lafong; E Crothers; K B Bamford; P J Rooney
Journal:  J Infect       Date:  1988-05       Impact factor: 6.072

4.  Serotype distribution of Streptococcus pneumoniae strains isolated from blood and cerebrospinal fluid in Sweden.

Authors:  L A Burman; B Trollfors; R Norrby; E Falsen; S Haidl; J Henrichsen
Journal:  Scand J Infect Dis       Date:  1986

5.  Bacterial meningitis in the United States in 1995. Active Surveillance Team.

Authors:  A Schuchat; K Robinson; J D Wenger; L H Harrison; M Farley; A L Reingold; L Lefkowitz; B A Perkins
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

6.  Predictors and outcome of admission for invasive Streptococcus pneumoniae infections at a Canadian children's hospital.

Authors:  K B Laupland; H D Davies; J D Kellner; N L Luzod; T Karan; D Ma; D Taub; C Nijssen-Jordan; G Katzko; T Jadavji; D Church
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

7.  Invasive pneumococcal infection in children, 1981-92: a hospital-based study.

Authors:  C W Davis; P B McIntyre
Journal:  J Paediatr Child Health       Date:  1995-08       Impact factor: 1.954

8.  Epidemiology of invasive pneumococcal infections in children in Finland.

Authors:  J Eskola; A K Takala; E Kela; E Pekkanen; R Kalliokoski; M Leinonen
Journal:  JAMA       Date:  1992-12-16       Impact factor: 56.272

9.  Pneumococcal meningitis and bacteraemia in Danish children 1969-1978. Serotypes, incidence and outcome.

Authors:  F K Pedersen; J Henrichsen
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-04

10.  Risk factors for primary invasive pneumococcal disease among children in Finland.

Authors:  A K Takala; J Jero; E Kela; P R Rönnberg; E Koskenniemi; J Eskola
Journal:  JAMA       Date:  1995-03-15       Impact factor: 56.272

View more
  8 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

2.  Persisting vasculitis after pneumococcal meningitis.

Authors:  Deborah Pugin; Jean-Christophe Copin; Marie-Christelle Goodyear; Theodor Landis; Yvan Gasche
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure.

Authors:  Timothy L McCavit; Charles T Quinn; Chonnamet Techasaensiri; Zora R Rogers
Journal:  J Pediatr       Date:  2010-12-28       Impact factor: 4.406

4.  High mortality of invasive pneumococcal disease compared with meningococcal disease in critically ill children.

Authors:  Kentigern Thorburn; Nia Taylor; Lucia Lopez-Rodriguez; Michael Ashworth; Miguel Angel de la Cal; Hendrik Karel Ferdinand van Saene
Journal:  Intensive Care Med       Date:  2005-09-16       Impact factor: 17.440

5.  Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Authors:  E D G McIntosh; B Fritzell; M A Fletcher
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

6.  Long-term outcomes of pneumococcal meningitis in childhood and adolescence.

Authors:  Deborah Christie; Russell M Viner; Kyle Knox; Pietro G Coen; Han Wang; Haitham El Bashir; Rosa Legood; Bharat C Patel; Robert Booy
Journal:  Eur J Pediatr       Date:  2011-01-19       Impact factor: 3.183

7.  Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.

Authors:  P Ispahani; R C B Slack; F E Donald; V C Weston; N Rutter
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

8.  Invasive pneumococcal disease complicated by cerebral vasculitis, transient diabetes insipidus and spondylodiscitis.

Authors:  Sofia Ribeiro; Vital Domingues; Raquel M Faria; Teresa Mendonça
Journal:  BMJ Case Rep       Date:  2013-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.